Chapter 155 The cooperation with Johnson & Johnson collapsed
“Mr. Zhang, I am Sun Xiaohua, executive vice president of Johnson & Johnson China, mainly responsible for marketing and business negotiation. I am very happy to meet you!”< br>
Two weeks after the third clinical phase of Tsingshan Pharmaceutical’s sAC male contraceptive was successfully launched, Johnson & Johnson’s China headquarters took the initiative to contact Tsingshan Pharmaceutical.
Zhang Yang was a little surprised at first, but he had to sigh that international giants like Johnson & Johnson have really high market acumen.
He immediately agreed to meet with Johnson & Johnson.
"Hello, President Sun, take a seat."
"Thank you."
Sun Xiaohua is a middle-aged man in his forties, very energetic, and sat down on the chair Then he ably took out the information carried in the briefcase and placed it on the conference table.
Then, he looked at Zhang Yang and said:
"Mr. Zhang, I am a relatively straightforward person, so I will get straight to the point."
"We have briefly communicated on the phone before, and the purpose of coming this time is for the male contraceptive that your company is currently undergoing clinical phase III trials!"
"As far as we know, your company The main business direction and sales focus have always been on hospital clinical drugs. This male contraceptive is not your company’s usual main drug.”
“And we, Johnson & Johnson, have sufficient advantages in this type of retail drugs, so we think there should be very good space for cooperation between us.”
“We hope to get expensive Do you think we can talk in detail about the company’s global exclusive rights to this male contraceptive pill? "
Zhang Yang smiled and glanced at Sun Xiaohua, who looked calm.
It can be seen that Sun Xiaohua's tone contains a sense of confidence when he speaks, and the content of his words is also very straightforward and does not use any so-called negotiation strategies.
He can completely understand. After all, Johnson & Johnson is the world's top pharmaceutical giant, and countless pharmaceutical companies around the world are looking forward to cooperating with Johnson & Johnson.
Because of this, they do have the ability and confidence to show absolute initiative in negotiations.
However, global agency rights are not necessary. Zhang Yang prefers to talk about US agency rights first.
"President Sun, we have no plans for a global exclusive agency agreement yet, but we can talk about market agency in the United States. I think you will also be very interested."
"After all, the United States is the world's largest consumer of contraceptive pills and is also Johnson & Johnson's home field."
"Is it just the U.S. market?"
Sun Xiaohua frowned slightly and reminded:
< br>"Mr. Zhang, if it is the agency authorization in the US market alone, the price may be very different from the exclusive agency rights in the global market."
Zhang Yang nodded insistently, with no intention of changing.
"Okay!"
Sun Xiaohua was a little disappointed, but he quickly took out a simple manuscript from the many materials and handed it to Zhang Yang.
"Mr. Zhang, this is a simple cooperation plan we have drafted."
"We hope to acquire your company's patent for this male contraceptive at one time, as long as you agree to transfer the patent Buy out the rights to develop, produce, and sell the drug in the U.S. market, and we can provide your company with a one-time payment of US$800 million. "
"After the third phase of clinical trials, your company can also receive one. A milestone clause of US$120 million.”
"And when the drug is actually put on the market and sales reaches 100 million U.S. dollars, your company will also receive a final reward of 50 million U.S. dollars."
"What do you think?"
< br>Zhang Yang lowered his head and looked at the various terms given by Johnson & Johnson.
Obviously, this is a very standard landmark BD deal.
But after a few glances, Zhang Yang put down the cooperation plan in his hand and said:
"President Sun, I currently have no idea of selling patents at once. We prefer the traditional dealer model! This is also the basis of our cooperation."
"Can you accept the traditional dealer and agent model? "
Sun Xiaohua was stunned for a moment, then shook his head and refused without thinking.
He knew very well that top US officials were very optimistic about the future sales prospects of this contraceptive pill. The advantage of buying out the patent at one time was naturally to be more confident and bold, and to invest more resources in promoting this drug.
The dealer model not only has meager profits, but also cannot fully control the pricing and initiative in the future.
This approach is obviously not what Johnson & Johnson wants.
"Mr. Zhang, if you insist on using the traditional dealer method, I think we may not be able to reach cooperation."
"Furthermore, I think even other retailers may be afraid of this method. No one is willing to accept it.”
“ Do you want to reconsider? Or we can talk about the price."
Zhang Yang shook his head without hesitation, not to mention the buyout terms of 800 million plus 120 million US dollars. Around 920 million, this amount of money is insignificant to Qingshan Pharmaceutical.
More importantly, as the first self-developed drug by Tsingshan Pharmaceutical, he had no reason to buy it out and sell it out. There was no need.
“I won’t consider this approach.”
“Okay.”
Sun Xiaohua from Johnson & Johnson obviously had no intention of giving in, and was immediately disappointed. Stand up:
"Mr. Zhang, in this case, there is no need to continue talking, but if you change your mind, you can contact us at any time." "Okay!"
Zhang Yang was originally quite excited when he received the call for cooperation from Johnson & Johnson, but after a brief conversation, he found that the core interests of both parties could not be cooperated at all.
This is normal,
Johnson & Johnson is super strong in the industry, and Qingshan Pharmaceutical or Zhang Yang also has its own bottom line.
It is difficult for two powerful pharmaceutical companies to make concessions and reach cooperation.
After the negotiation with Johnson & Johnson collapsed, Zhang Yang realized that this male contraceptive pill was in a somewhat embarrassing situation.
Top pharmaceutical companies like Novartis have little interest, while pharmaceutical companies like Johnson & Johnson, which have an absolute say in the retail industry, have no chance of reaching cooperation.
Although Ren Xiaomin also contacted some smaller drug retailers in the United States through some business channels in the next few days, on the whole, either Zhang Yang was not satisfied, or the other parties also preferred disposable products like Johnson & Johnson. Buying out the patent for male contraceptive pills.
The advancement of Qingshan Pharmaceutical’s sAC male contraceptive pill in North America suddenly came to a halt.
“Forget it, Brother Ren, let’s not think about this matter for now. I think we should contact Novartis first and ask them to help start clinical trials!”
"While we are advancing clinical trials, we are also looking for suitable cooperative agents. But it really doesn't work. We can only try to develop the market in the United States ourselves!"
"Well, that's the only way!"
After discussing with Ren Xiaomin, Zhang Yang also knew that the most important thing at present was to promote the clinical trial of "sAC male contraceptive" as soon as possible, and then contacted Friedman of Novartis to help carry out the clinical trial of "sAC male contraceptive". clinical trials.
Friedman was willing to help with this small favor, not to mention that Zhang Yang offered to have Qingshan Pharmaceutical pay for all clinical trial expenses.
Two days later, the two parties signed a commission agreement, and a large amount of clinical trial data was sent to Novartis, who then helped start clinical trials of the "sAC male contraceptive".
And just when the "sAC male contraceptive pill" was being promoted for clinical trials in the US FDA, the domestic clinical phase III trials also attracted more and more people's attention.
No way.
With the continuous launch of top drugs such as "Hepatocyte Activator" and "Shenduqing", Qingshan Pharmaceutical has become the top player in the domestic pharmaceutical industry. Any clinical trial applied for The drugs have received widespread attention both inside and outside the industry.
After all, everyone wants to know where Qingshan Pharmaceutical’s next research and development direction will be.
As the Phase III clinical trials of the "sAC Male Contraceptive Pill" were carried out in depth, many medical media soon discovered that the effective contraceptive rate of the "sAC Male Contraceptive Pill" had increased from more than 40% in the second phase to as high as 98.5%, which immediately attracted everyone’s attention.
You know, once it is successfully launched, this will be the world's first male contraceptive pill!
The media were quite excited, but when news of the "sAC male contraceptive pill" gradually appeared in front of the public, the mainstream comments from many domestic men were unexpected.
“The world’s first male contraceptive pill... How should I put it? I don’t think a pharmaceutical company as powerful as Tsingshan Pharmaceuticals needs to develop contraceptive pills, right? If you have the energy, why not develop other drugs? ? ”
“That’s right! I think the current contraceptive methods are very good. Women can use the ring, right? ”< br>
“Tsk, tsk, tsk, if it weren’t for the fact that you are Qingshan Pharmaceuticals, I would have to criticize you. Aren’t you trying to create family conflicts? My wife asked me to get a sterilization a few days ago. , I finally convinced her of the dangers of sterilization and let her get the ring. Are you going to introduce male contraceptive pills so soon? "
"I agree with you upstairs. Anyway, I don't take male contraceptive pills. What if I have side effects and die? Isn't it good to wear condoms and condoms now?"
"Haha, you don't want to take it? You don’t even realize what the biggest harm this contraceptive pill will do to men!
I’m afraid that once it becomes popular, What are you going to do if you don’t want to eat?”
“Hey, we still have to eat like this?”
"Damn, can you strongly boycott this male contraceptive pill from Qingshan Pharmaceutical before it goes on the market?!"
Zhang Yang originally did not have high hopes for the domestic market, so when many media reported on the "sAC male contraceptive pill", he did not take the opportunity to promote it.
Despite this, he still did not expect that the "sAC male contraceptive pill" would be boycotted by many male groups before it was even launched on the market...
This is the first time in the history of Qingshan Pharmaceutical This happened once.
However, compared to the resistance of the vast majority of men, women who saw the news were extremely excited and said that they would rely on men for contraception in the future.
“Qingshan Pharmaceutical is so considerate. When will this male contraceptive pill be launched? Now that I’m in a relationship, I’m afraid of getting pregnant. Every time I’m in a relationship, I have to wear a condom or take birth control pills... I’ll find a willing partner in the future. Men who take birth control pills for me don’t love me enough.”
"Yes, why are they so happy that they want us to take contraceptive pills! If you really love us, take birth control pills yourself! If you don't take them, don't touch us!"
"That's right, Jimei, the best way is It's better to buy male contraceptive pills in advance and let him take them in front of you every time."
"I love Qingshan Pharmaceutical so much about contraception. It can’t all be left to girls. I really hope that Qingshan Pharmaceutical can develop another drug that can make men pregnant. By then, Jimei people will only need the beautiful ones.”
Zhang Yangye. Noticing these outrageous comments, he did not seem excited by the woman's enthusiasm and excitement. In fact, he had vaguely noticed something was wrong.
Originally, the target group of this male contraceptive pill was supposed to be married men with regular partners, giving such partners more contraceptive options.
But now, the discussions between men and women on the Internet were so tit-for-tat before it was even launched on the market, and he even had the slightest idea of delaying the launch.
Zhang Yang was hesitant and simply focused all his attention on the US FDA certification.
He is still a little worried about the situation at home, but he doesn't care about the repercussions of this drug after it is launched abroad.
Unexpectedly,
After more than one and two months of clinical phase I trials, the "sAC male contraceptive pill" has advanced to clinical phase II.
Judging from the recruitment speed of the second clinical phase, the popularity of "sAC male contraceptive pill" among foreign men seems to be much higher than that in China!
Not long after the Phase II clinical recruitment plan came out, a large number of men rushed to participate in just a few days!
(End of this chapter)